NCT02613416View on ClinicalTrials.gov

Denosumab and MRI Breast Imaging

PHASE2CompletedINTERVENTIONAL

Enrollment

42

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

August 20, 2021

Study Completion Date

August 20, 2021

Conditions

Breast Cancer

Interventions

DRUG

Denosumab

monthly subcutaneous injections

Trial Locations (1)

11794

Stony Brook University Cancer Center, Stony Brook

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Amgen

INDUSTRY

lead

Alison Stopeck

OTHER